Dataset Information


Efficacy of Single-Pill Combination of Telmisartan 80?mg and Hydrochlorothiazide 25?mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial.

ABSTRACT: Objective. Report of prespecified and post hoc subgroup analyses of a randomized, controlled trial comparing telmisartan 80?mg/hydrochlorothiazide 25?mg (T80/H25) combination therapy with T80 monotherapy, according to the presence of cardiovascular disease (CVD) risk factors. Methods. Hypertensive patients were randomized (2?:?1) to receive T80/H25 or T80 for 6 weeks, following a 1-week, low-dose, and run-in period. Systolic blood pressure (SBP) and diastolic BP reductions and BP goal achievement were evaluated in patients with CVD risk factors: presence of diabetes mellitus (DM), renal impairment, increased body mass index (BMI), and 10-year estimated risk for coronary heart disease (CHD). Results. In total, 888 patients received treatment. Overall, T80/H25 therapy significantly reduced SBP more than T80 monotherapy, irrespective of patient subgroup. In patients with DM, renal impairment, high BMI, and high CHD risk, BP goal achievement rates (<140/90?mm?Hg) at Week 7, among those treated with T80/H25, were 52.8%, 52.8%, 50.6%, and 38.5%, respectively. More patients with DM reached a guideline-based BP goal (<130/80?mm?Hg) at 7 weeks with T80/H25 than with T80 monotherapy (16.7% versus 8.8%). Rates of treatment-related adverse events were low and comparable across patient subgroups. Conclusions. Antihypertensive treatment with T80/H25 single-pill combination is effective and generally well tolerated, irrespective of the presence of CVD risk factors.


PROVIDER: S-EPMC3638649 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3636767 | BioStudies
2013-01-01 | S-EPMC3703394 | BioStudies
2012-01-01 | S-EPMC3954024 | BioStudies
1000-01-01 | S-EPMC5222993 | BioStudies
2014-01-01 | S-EPMC3955615 | BioStudies
2016-01-01 | S-EPMC4839178 | BioStudies
| S-EPMC6201393 | BioStudies
2010-01-01 | S-EPMC2897053 | BioStudies
1000-01-01 | S-EPMC5996509 | BioStudies
| S-EPMC6744976 | BioStudies